PDE1B
Basic information
Region (hg38): 12:54549601-54579239
Previous symbols: [ "PDES1B" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE1B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 27 | 27 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 0 | 1 |
Variants in PDE1B
This is a list of pathogenic ClinVar variants found in the PDE1B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-54549925-C-A | not specified | Uncertain significance (Dec 02, 2024) | ||
12-54549979-G-C | not specified | Uncertain significance (Dec 13, 2023) | ||
12-54566979-G-A | not specified | Uncertain significance (Jun 26, 2024) | ||
12-54567018-T-C | not specified | Uncertain significance (Jan 16, 2025) | ||
12-54567080-G-A | not specified | Uncertain significance (Nov 14, 2023) | ||
12-54567086-C-T | not specified | Uncertain significance (Dec 02, 2022) | ||
12-54569212-C-T | Hypotonia;Cerebellar ataxia;Intellectual disability, moderate;Delayed speech and language development | Uncertain significance (Jun 20, 2023) | ||
12-54569240-C-T | not specified | Uncertain significance (Sep 09, 2024) | ||
12-54569248-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
12-54569345-A-G | not specified | Uncertain significance (Jun 09, 2022) | ||
12-54569358-C-T | Benign (Dec 31, 2019) | |||
12-54569605-G-A | not specified | Uncertain significance (Apr 30, 2024) | ||
12-54570258-C-G | not specified | Uncertain significance (Nov 29, 2023) | ||
12-54570295-C-A | not specified | Uncertain significance (Feb 11, 2025) | ||
12-54570337-A-G | not specified | Uncertain significance (Apr 08, 2022) | ||
12-54572746-G-A | Hypotonia;Cerebellar ataxia;Intellectual disability, moderate;Delayed speech and language development | Uncertain significance (Jun 20, 2023) | ||
12-54573239-T-C | not specified | Uncertain significance (Aug 10, 2021) | ||
12-54573374-T-C | not specified | Uncertain significance (Dec 20, 2022) | ||
12-54573423-G-A | not specified | Uncertain significance (Jul 25, 2024) | ||
12-54573630-G-C | not specified | Uncertain significance (Oct 20, 2024) | ||
12-54573663-T-A | not specified | Uncertain significance (Aug 21, 2024) | ||
12-54575599-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
12-54576038-C-G | not specified | Uncertain significance (Feb 07, 2025) | ||
12-54576057-C-G | not specified | Uncertain significance (Jun 18, 2021) | ||
12-54576061-C-T | not specified | Uncertain significance (Jan 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDE1B | protein_coding | protein_coding | ENST00000243052 | 14 | 29890 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.336 | 0.664 | 125727 | 0 | 21 | 125748 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.27 | 203 | 317 | 0.641 | 0.0000181 | 3535 |
Missense in Polyphen | 37 | 91.182 | 0.40578 | 961 | ||
Synonymous | 1.39 | 102 | 122 | 0.839 | 0.00000677 | 1019 |
Loss of Function | 3.95 | 7 | 30.6 | 0.229 | 0.00000166 | 334 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000304 | 0.000304 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000798 | 0.0000791 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Cyclic nucleotide phosphodiesterase with a dual- specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes. Has a preference for cGMP as a substrate. {ECO:0000269|PubMed:15260978}.;
- Pathway
- Calcium signaling pathway - Homo sapiens (human);Renin secretion - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Taste transduction - Homo sapiens (human);Olfactory transduction - Homo sapiens (human);Morphine addiction - Homo sapiens (human);G Protein Signaling Pathways;Phosphodiesterases in neuronal function;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Calmodulin induced events;CaM pathway;Cam-PDE 1 activation;Purine nucleotides nucleosides metabolism;Hemostasis;DAG and IP3 signaling;Ca-dependent events;PLC beta mediated events;G-protein mediated events;Opioid Signalling;G alpha (i) signalling events;cGMP effects;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;GPCR downstream signalling;Intracellular signaling by second messengers
(Consensus)
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.394
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 42.06
Haploinsufficiency Scores
- pHI
- 0.384
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.573
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.100
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pde1b
- Phenotype
- vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- response to amphetamine;apoptotic process;G protein-coupled receptor signaling pathway;locomotory behavior;visual learning;monocyte differentiation;cellular response to macrophage colony-stimulating factor stimulus;regulation of dopamine metabolic process;serotonin metabolic process;cellular response to granulocyte macrophage colony-stimulating factor stimulus
- Cellular component
- cytosol;neuronal cell body
- Molecular function
- 3',5'-cyclic-AMP phosphodiesterase activity;calmodulin-dependent cyclic-nucleotide phosphodiesterase activity;protein binding;calmodulin binding;metal ion binding;3',5'-cyclic-GMP phosphodiesterase activity;calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity